Gaetano La Manna

The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

Éric Rondeau, Marie Scully, Gema Ariceta et al. · Kidney International · 2020 · 219 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Recurrence of FSGS after Kidney Transplantation in Adults

Audrey Uffing, María José Pérez‐Sáez, Marilda Mazzali et al. · Clinical Journal of the American Society of Nephrology · 2020 · 193 citations · Full text

Medicine, Nephrology, Surgery +17

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society

Giuseppe Boriani, Irina Savelieva, Gheorghe‐Andrei Dan et al. · EP Europace · 2015 · 185 citations · Full text

Medicine, Cardiology, Nephrology +17

Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis

Andrea Angeletti, Chiara Cantarelli, Astgik Petrosyan et al. · The Journal of Experimental Medicine · 2020 · 138 citations · Full text

Medicine, Nephrology, Pathobiology +17